Recreating Liver Tumors As Organoids For Faster, More Accurate Drug Screening

News A major challenge in developing liver cancer drugs is that preclinical testing occurs in tumor models that do not accurately reflect human tumor features, causing drug candidates to later fail in clinical testing. Now, Singaporean researchers have grown... Contributed Author: National University of Singapore, Yong Loo Lin School of Medicine Topics: Oncology